nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Vincristine—muscle cancer	0.0802	0.344	CbGbCtD
Vardenafil—CYP3A5—Etoposide—muscle cancer	0.0735	0.315	CbGbCtD
Vardenafil—CYP3A4—Vincristine—muscle cancer	0.0313	0.134	CbGbCtD
Vardenafil—CYP3A4—Etoposide—muscle cancer	0.0287	0.123	CbGbCtD
Vardenafil—CYP3A4—Doxorubicin—muscle cancer	0.0196	0.0838	CbGbCtD
Vardenafil—PDE11A—tendon—muscle cancer	0.0173	0.0999	CbGeAlD
Vardenafil—PDE6H—head—muscle cancer	0.0148	0.0857	CbGeAlD
Vardenafil—PDE11A—testis—muscle cancer	0.0143	0.0827	CbGeAlD
Vardenafil—PDE6G—head—muscle cancer	0.0142	0.0824	CbGeAlD
Vardenafil—PDE6G—testis—muscle cancer	0.0138	0.0796	CbGeAlD
Vardenafil—PDE10A—tendon—muscle cancer	0.0112	0.065	CbGeAlD
Vardenafil—PDE10A—head—muscle cancer	0.00962	0.0557	CbGeAlD
Vardenafil—PDE1B—head—muscle cancer	0.00954	0.0552	CbGeAlD
Vardenafil—PDE10A—testis—muscle cancer	0.00929	0.0538	CbGeAlD
Vardenafil—PDE1B—testis—muscle cancer	0.00921	0.0533	CbGeAlD
Vardenafil—PDE5A—smooth muscle tissue—muscle cancer	0.00874	0.0506	CbGeAlD
Vardenafil—PDE5A—renal system—muscle cancer	0.00841	0.0487	CbGeAlD
Vardenafil—PDE5A—tendon—muscle cancer	0.00657	0.038	CbGeAlD
Vardenafil—PDE5A—vagina—muscle cancer	0.00609	0.0353	CbGeAlD
Vardenafil—PDE5A—head—muscle cancer	0.00563	0.0326	CbGeAlD
Vardenafil—PDE5A—testis—muscle cancer	0.00544	0.0315	CbGeAlD
Vardenafil—CYP3A5—renal system—muscle cancer	0.0035	0.0202	CbGeAlD
Vardenafil—CYP3A4—renal system—muscle cancer	0.00262	0.0152	CbGeAlD
Vardenafil—Lacrimation increased—Doxorubicin—muscle cancer	0.00261	0.00439	CcSEcCtD
Vardenafil—Angiopathy—Vincristine—muscle cancer	0.00261	0.00439	CcSEcCtD
Vardenafil—Ill-defined disorder—Dactinomycin—muscle cancer	0.0026	0.00437	CcSEcCtD
Vardenafil—Infestation NOS—Etoposide—muscle cancer	0.00259	0.00436	CcSEcCtD
Vardenafil—Infestation—Etoposide—muscle cancer	0.00259	0.00436	CcSEcCtD
Vardenafil—Mediastinal disorder—Vincristine—muscle cancer	0.00259	0.00436	CcSEcCtD
Vardenafil—Acute coronary syndrome—Etoposide—muscle cancer	0.00255	0.0043	CcSEcCtD
Vardenafil—Myocardial infarction—Etoposide—muscle cancer	0.00254	0.00428	CcSEcCtD
Vardenafil—CYP3A5—vagina—muscle cancer	0.00253	0.0147	CbGeAlD
Vardenafil—Creatinine increased—Doxorubicin—muscle cancer	0.00252	0.00425	CcSEcCtD
Vardenafil—Malaise—Dactinomycin—muscle cancer	0.00252	0.00425	CcSEcCtD
Vardenafil—Mental disorder—Vincristine—muscle cancer	0.00252	0.00424	CcSEcCtD
Vardenafil—Hepatobiliary disease—Etoposide—muscle cancer	0.00245	0.00413	CcSEcCtD
Vardenafil—Neck pain—Doxorubicin—muscle cancer	0.00243	0.0041	CcSEcCtD
Vardenafil—Back pain—Vincristine—muscle cancer	0.00242	0.00407	CcSEcCtD
Vardenafil—Myalgia—Dactinomycin—muscle cancer	0.00238	0.00401	CcSEcCtD
Vardenafil—Discomfort—Dactinomycin—muscle cancer	0.00235	0.00396	CcSEcCtD
Vardenafil—Influenza like illness—Doxorubicin—muscle cancer	0.00233	0.00393	CcSEcCtD
Vardenafil—Hypoaesthesia—Etoposide—muscle cancer	0.00232	0.0039	CcSEcCtD
Vardenafil—Urinary tract disorder—Etoposide—muscle cancer	0.0023	0.00387	CcSEcCtD
Vardenafil—Urethral disorder—Etoposide—muscle cancer	0.00228	0.00384	CcSEcCtD
Vardenafil—Infection—Dactinomycin—muscle cancer	0.00227	0.00382	CcSEcCtD
Vardenafil—Vertigo—Vincristine—muscle cancer	0.00225	0.00378	CcSEcCtD
Vardenafil—Oesophagitis—Doxorubicin—muscle cancer	0.0022	0.0037	CcSEcCtD
Vardenafil—Eye disorder—Etoposide—muscle cancer	0.00217	0.00366	CcSEcCtD
Vardenafil—Convulsion—Vincristine—muscle cancer	0.00217	0.00365	CcSEcCtD
Vardenafil—Flushing—Etoposide—muscle cancer	0.00216	0.00364	CcSEcCtD
Vardenafil—Cardiac disorder—Etoposide—muscle cancer	0.00216	0.00364	CcSEcCtD
Vardenafil—Myalgia—Vincristine—muscle cancer	0.00213	0.00358	CcSEcCtD
Vardenafil—Visual disturbance—Methotrexate—muscle cancer	0.00213	0.00358	CcSEcCtD
Vardenafil—Angiopathy—Etoposide—muscle cancer	0.00211	0.00355	CcSEcCtD
Vardenafil—Hypertonia—Doxorubicin—muscle cancer	0.00211	0.00355	CcSEcCtD
Vardenafil—Immune system disorder—Etoposide—muscle cancer	0.0021	0.00354	CcSEcCtD
Vardenafil—Mediastinal disorder—Etoposide—muscle cancer	0.0021	0.00353	CcSEcCtD
Vardenafil—Abnormal vision—Doxorubicin—muscle cancer	0.0021	0.00353	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00208	0.0035	CcSEcCtD
Vardenafil—Anaphylactic shock—Vincristine—muscle cancer	0.00204	0.00344	CcSEcCtD
Vardenafil—Infection—Vincristine—muscle cancer	0.00203	0.00341	CcSEcCtD
Vardenafil—Nervous system disorder—Vincristine—muscle cancer	0.002	0.00337	CcSEcCtD
Vardenafil—Hyperhidrosis—Vincristine—muscle cancer	0.00197	0.00332	CcSEcCtD
Vardenafil—Back pain—Etoposide—muscle cancer	0.00196	0.0033	CcSEcCtD
Vardenafil—Pain—Dactinomycin—muscle cancer	0.00195	0.00329	CcSEcCtD
Vardenafil—Muscle spasms—Etoposide—muscle cancer	0.00195	0.00328	CcSEcCtD
Vardenafil—Eye pain—Doxorubicin—muscle cancer	0.00193	0.00325	CcSEcCtD
Vardenafil—Hypotension—Vincristine—muscle cancer	0.00191	0.00321	CcSEcCtD
Vardenafil—Feeling abnormal—Dactinomycin—muscle cancer	0.00188	0.00317	CcSEcCtD
Vardenafil—Ill-defined disorder—Etoposide—muscle cancer	0.00188	0.00316	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00187	0.00314	CcSEcCtD
Vardenafil—Hot flush—Doxorubicin—muscle cancer	0.00186	0.00314	CcSEcCtD
Vardenafil—Liver function test abnormal—Methotrexate—muscle cancer	0.00186	0.00313	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00186	0.00313	CcSEcCtD
Vardenafil—Menopausal symptoms—Doxorubicin—muscle cancer	0.00185	0.00311	CcSEcCtD
Vardenafil—Insomnia—Vincristine—muscle cancer	0.00185	0.00311	CcSEcCtD
Vardenafil—Paraesthesia—Vincristine—muscle cancer	0.00183	0.00309	CcSEcCtD
Vardenafil—Malaise—Etoposide—muscle cancer	0.00183	0.00308	CcSEcCtD
Vardenafil—Breast disorder—Methotrexate—muscle cancer	0.00182	0.00307	CcSEcCtD
Vardenafil—Vertigo—Etoposide—muscle cancer	0.00182	0.00306	CcSEcCtD
Vardenafil—Abdominal pain—Dactinomycin—muscle cancer	0.00181	0.00304	CcSEcCtD
Vardenafil—Loss of consciousness—Etoposide—muscle cancer	0.00178	0.003	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Vincristine—muscle cancer	0.00176	0.00297	CcSEcCtD
Vardenafil—Convulsion—Etoposide—muscle cancer	0.00175	0.00295	CcSEcCtD
Vardenafil—Pain—Vincristine—muscle cancer	0.00174	0.00294	CcSEcCtD
Vardenafil—Chest pain—Etoposide—muscle cancer	0.00172	0.0029	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00171	0.00288	CcSEcCtD
Vardenafil—Discomfort—Etoposide—muscle cancer	0.0017	0.00287	CcSEcCtD
Vardenafil—Face oedema—Doxorubicin—muscle cancer	0.00168	0.00284	CcSEcCtD
Vardenafil—Hypersensitivity—Dactinomycin—muscle cancer	0.00168	0.00283	CcSEcCtD
Vardenafil—Gastrointestinal pain—Vincristine—muscle cancer	0.00167	0.00281	CcSEcCtD
Vardenafil—Anaphylactic shock—Etoposide—muscle cancer	0.00165	0.00278	CcSEcCtD
Vardenafil—Infection—Etoposide—muscle cancer	0.00164	0.00277	CcSEcCtD
Vardenafil—Asthenia—Dactinomycin—muscle cancer	0.00164	0.00276	CcSEcCtD
Vardenafil—Blood creatinine increased—Doxorubicin—muscle cancer	0.00163	0.00275	CcSEcCtD
Vardenafil—Tachycardia—Etoposide—muscle cancer	0.00161	0.00272	CcSEcCtD
Vardenafil—Abdominal pain—Vincristine—muscle cancer	0.00161	0.00272	CcSEcCtD
Vardenafil—Liver function test abnormal—Doxorubicin—muscle cancer	0.00161	0.00271	CcSEcCtD
Vardenafil—Skin disorder—Etoposide—muscle cancer	0.00161	0.0027	CcSEcCtD
Vardenafil—Hyperhidrosis—Etoposide—muscle cancer	0.0016	0.00269	CcSEcCtD
Vardenafil—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00159	0.00268	CcSEcCtD
Vardenafil—Abdominal pain upper—Doxorubicin—muscle cancer	0.00159	0.00268	CcSEcCtD
Vardenafil—Photosensitivity reaction—Methotrexate—muscle cancer	0.00159	0.00268	CcSEcCtD
Vardenafil—Breast disorder—Doxorubicin—muscle cancer	0.00158	0.00265	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00157	0.00264	CcSEcCtD
Vardenafil—Diarrhoea—Dactinomycin—muscle cancer	0.00156	0.00263	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—muscle cancer	0.00155	0.00261	CcSEcCtD
Vardenafil—Infestation—Methotrexate—muscle cancer	0.00155	0.00261	CcSEcCtD
Vardenafil—Hypotension—Etoposide—muscle cancer	0.00154	0.0026	CcSEcCtD
Vardenafil—Gastritis—Doxorubicin—muscle cancer	0.00154	0.0026	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00154	0.00259	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—muscle cancer	0.00151	0.00254	CcSEcCtD
Vardenafil—Influenza—Doxorubicin—muscle cancer	0.00151	0.00254	CcSEcCtD
Vardenafil—Dysphagia—Doxorubicin—muscle cancer	0.00151	0.00254	CcSEcCtD
Vardenafil—Hypersensitivity—Vincristine—muscle cancer	0.0015	0.00253	CcSEcCtD
Vardenafil—Sweating—Methotrexate—muscle cancer	0.00149	0.00251	CcSEcCtD
Vardenafil—Paraesthesia—Etoposide—muscle cancer	0.00148	0.0025	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—muscle cancer	0.00148	0.00249	CcSEcCtD
Vardenafil—Dyspnoea—Etoposide—muscle cancer	0.00147	0.00248	CcSEcCtD
Vardenafil—Somnolence—Etoposide—muscle cancer	0.00147	0.00247	CcSEcCtD
Vardenafil—Angina pectoris—Doxorubicin—muscle cancer	0.00147	0.00247	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—muscle cancer	0.00147	0.00247	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—muscle cancer	0.00146	0.00247	CcSEcCtD
Vardenafil—Asthenia—Vincristine—muscle cancer	0.00146	0.00247	CcSEcCtD
Vardenafil—Vomiting—Dactinomycin—muscle cancer	0.00145	0.00245	CcSEcCtD
Vardenafil—Rash—Dactinomycin—muscle cancer	0.00144	0.00242	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Etoposide—muscle cancer	0.00143	0.0024	CcSEcCtD
Vardenafil—Pain—Etoposide—muscle cancer	0.00141	0.00238	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—muscle cancer	0.0014	0.00236	CcSEcCtD
Vardenafil—Diarrhoea—Vincristine—muscle cancer	0.0014	0.00235	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—muscle cancer	0.00139	0.00235	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—muscle cancer	0.00138	0.00233	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—muscle cancer	0.00138	0.00232	CcSEcCtD
Vardenafil—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00138	0.00232	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—muscle cancer	0.00137	0.0023	CcSEcCtD
Vardenafil—Feeling abnormal—Etoposide—muscle cancer	0.00136	0.00229	CcSEcCtD
Vardenafil—Nausea—Dactinomycin—muscle cancer	0.00136	0.00228	CcSEcCtD
Vardenafil—Gastrointestinal pain—Etoposide—muscle cancer	0.00135	0.00228	CcSEcCtD
Vardenafil—Dizziness—Vincristine—muscle cancer	0.00135	0.00227	CcSEcCtD
Vardenafil—Infestation—Doxorubicin—muscle cancer	0.00134	0.00226	CcSEcCtD
Vardenafil—Infestation NOS—Doxorubicin—muscle cancer	0.00134	0.00226	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—muscle cancer	0.00134	0.00226	CcSEcCtD
Vardenafil—Abdominal pain—Etoposide—muscle cancer	0.00131	0.0022	CcSEcCtD
Vardenafil—Conjunctivitis—Doxorubicin—muscle cancer	0.00131	0.0022	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—muscle cancer	0.0013	0.00219	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—muscle cancer	0.0013	0.00219	CcSEcCtD
Vardenafil—Vomiting—Vincristine—muscle cancer	0.0013	0.00218	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—muscle cancer	0.00129	0.00218	CcSEcCtD
Vardenafil—Sweating—Doxorubicin—muscle cancer	0.00129	0.00217	CcSEcCtD
Vardenafil—Rash—Vincristine—muscle cancer	0.00129	0.00217	CcSEcCtD
Vardenafil—Dermatitis—Vincristine—muscle cancer	0.00129	0.00216	CcSEcCtD
Vardenafil—Haematuria—Doxorubicin—muscle cancer	0.00128	0.00216	CcSEcCtD
Vardenafil—Headache—Vincristine—muscle cancer	0.00128	0.00215	CcSEcCtD
Vardenafil—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00127	0.00214	CcSEcCtD
Vardenafil—Epistaxis—Doxorubicin—muscle cancer	0.00127	0.00213	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—muscle cancer	0.00126	0.00213	CcSEcCtD
Vardenafil—Sinusitis—Doxorubicin—muscle cancer	0.00126	0.00212	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—muscle cancer	0.00126	0.00212	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—muscle cancer	0.00126	0.00211	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—muscle cancer	0.00122	0.00206	CcSEcCtD
Vardenafil—Hypersensitivity—Etoposide—muscle cancer	0.00122	0.00205	CcSEcCtD
Vardenafil—Erythema—Methotrexate—muscle cancer	0.00121	0.00204	CcSEcCtD
Vardenafil—Haemoglobin—Doxorubicin—muscle cancer	0.00121	0.00204	CcSEcCtD
Vardenafil—Nausea—Vincristine—muscle cancer	0.00121	0.00204	CcSEcCtD
Vardenafil—Rhinitis—Doxorubicin—muscle cancer	0.00121	0.00204	CcSEcCtD
Vardenafil—Haemorrhage—Doxorubicin—muscle cancer	0.00121	0.00203	CcSEcCtD
Vardenafil—Hypoaesthesia—Doxorubicin—muscle cancer	0.0012	0.00202	CcSEcCtD
Vardenafil—Pharyngitis—Doxorubicin—muscle cancer	0.0012	0.00202	CcSEcCtD
Vardenafil—Urinary tract disorder—Doxorubicin—muscle cancer	0.00119	0.00201	CcSEcCtD
Vardenafil—Asthenia—Etoposide—muscle cancer	0.00119	0.002	CcSEcCtD
Vardenafil—Connective tissue disorder—Doxorubicin—muscle cancer	0.00119	0.002	CcSEcCtD
Vardenafil—Urethral disorder—Doxorubicin—muscle cancer	0.00118	0.00199	CcSEcCtD
Vardenafil—Back pain—Methotrexate—muscle cancer	0.00117	0.00198	CcSEcCtD
Vardenafil—Pruritus—Etoposide—muscle cancer	0.00117	0.00197	CcSEcCtD
Vardenafil—Visual impairment—Doxorubicin—muscle cancer	0.00116	0.00196	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—muscle cancer	0.00114	0.00193	CcSEcCtD
Vardenafil—Diarrhoea—Etoposide—muscle cancer	0.00113	0.0019	CcSEcCtD
Vardenafil—Eye disorder—Doxorubicin—muscle cancer	0.00113	0.0019	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—muscle cancer	0.00113	0.0019	CcSEcCtD
Vardenafil—Tinnitus—Doxorubicin—muscle cancer	0.00113	0.00189	CcSEcCtD
Vardenafil—Flushing—Doxorubicin—muscle cancer	0.00112	0.00189	CcSEcCtD
Vardenafil—Cardiac disorder—Doxorubicin—muscle cancer	0.00112	0.00189	CcSEcCtD
Vardenafil—Angiopathy—Doxorubicin—muscle cancer	0.00109	0.00184	CcSEcCtD
Vardenafil—Malaise—Methotrexate—muscle cancer	0.00109	0.00184	CcSEcCtD
Vardenafil—Dizziness—Etoposide—muscle cancer	0.00109	0.00184	CcSEcCtD
Vardenafil—Immune system disorder—Doxorubicin—muscle cancer	0.00109	0.00184	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—muscle cancer	0.00109	0.00184	CcSEcCtD
Vardenafil—Mediastinal disorder—Doxorubicin—muscle cancer	0.00109	0.00183	CcSEcCtD
Vardenafil—Mental disorder—Doxorubicin—muscle cancer	0.00106	0.00178	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—muscle cancer	0.00105	0.00177	CcSEcCtD
Vardenafil—Vomiting—Etoposide—muscle cancer	0.00105	0.00177	CcSEcCtD
Vardenafil—Erythema—Doxorubicin—muscle cancer	0.00105	0.00177	CcSEcCtD
Vardenafil—Rash—Etoposide—muscle cancer	0.00104	0.00175	CcSEcCtD
Vardenafil—Dermatitis—Etoposide—muscle cancer	0.00104	0.00175	CcSEcCtD
Vardenafil—Headache—Etoposide—muscle cancer	0.00104	0.00174	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—muscle cancer	0.00103	0.00174	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—muscle cancer	0.00103	0.00174	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—muscle cancer	0.00103	0.00174	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00103	0.00173	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—muscle cancer	0.00102	0.00172	CcSEcCtD
Vardenafil—Back pain—Doxorubicin—muscle cancer	0.00102	0.00171	CcSEcCtD
Vardenafil—Muscle spasms—Doxorubicin—muscle cancer	0.00101	0.0017	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—muscle cancer	0.00099	0.00167	CcSEcCtD
Vardenafil—Vision blurred—Doxorubicin—muscle cancer	0.00099	0.00167	CcSEcCtD
Vardenafil—Infection—Methotrexate—muscle cancer	0.000984	0.00166	CcSEcCtD
Vardenafil—Nausea—Etoposide—muscle cancer	0.000982	0.00165	CcSEcCtD
Vardenafil—Ill-defined disorder—Doxorubicin—muscle cancer	0.000975	0.00164	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—muscle cancer	0.000971	0.00163	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—muscle cancer	0.000962	0.00162	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—muscle cancer	0.000957	0.00161	CcSEcCtD
Vardenafil—Malaise—Doxorubicin—muscle cancer	0.000947	0.0016	CcSEcCtD
Vardenafil—Vertigo—Doxorubicin—muscle cancer	0.000944	0.00159	CcSEcCtD
Vardenafil—Syncope—Doxorubicin—muscle cancer	0.000942	0.00159	CcSEcCtD
Vardenafil—Palpitations—Doxorubicin—muscle cancer	0.000928	0.00156	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—muscle cancer	0.000925	0.00156	CcSEcCtD
Vardenafil—Loss of consciousness—Doxorubicin—muscle cancer	0.000923	0.00155	CcSEcCtD
Vardenafil—Convulsion—Doxorubicin—muscle cancer	0.00091	0.00153	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000902	0.00152	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—muscle cancer	0.000896	0.00151	CcSEcCtD
Vardenafil—Chest pain—Doxorubicin—muscle cancer	0.000894	0.00151	CcSEcCtD
Vardenafil—Myalgia—Doxorubicin—muscle cancer	0.000894	0.00151	CcSEcCtD
Vardenafil—Arthralgia—Doxorubicin—muscle cancer	0.000894	0.00151	CcSEcCtD
Vardenafil—Anxiety—Doxorubicin—muscle cancer	0.000891	0.0015	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—muscle cancer	0.000889	0.0015	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000888	0.0015	CcSEcCtD
Vardenafil—Discomfort—Doxorubicin—muscle cancer	0.000884	0.00149	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—muscle cancer	0.000883	0.00149	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—muscle cancer	0.00088	0.00148	CcSEcCtD
Vardenafil—Dry mouth—Doxorubicin—muscle cancer	0.000875	0.00147	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—muscle cancer	0.000872	0.00147	CcSEcCtD
Vardenafil—Anaphylactic shock—Doxorubicin—muscle cancer	0.000857	0.00144	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000855	0.00144	CcSEcCtD
Vardenafil—Infection—Doxorubicin—muscle cancer	0.000852	0.00143	CcSEcCtD
Vardenafil—Pain—Methotrexate—muscle cancer	0.000847	0.00143	CcSEcCtD
Vardenafil—Shock—Doxorubicin—muscle cancer	0.000844	0.00142	CcSEcCtD
Vardenafil—Nervous system disorder—Doxorubicin—muscle cancer	0.000841	0.00142	CcSEcCtD
Vardenafil—Tachycardia—Doxorubicin—muscle cancer	0.000837	0.00141	CcSEcCtD
Vardenafil—Skin disorder—Doxorubicin—muscle cancer	0.000833	0.0014	CcSEcCtD
Vardenafil—Hyperhidrosis—Doxorubicin—muscle cancer	0.000829	0.0014	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—muscle cancer	0.000816	0.00137	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—muscle cancer	0.00081	0.00136	CcSEcCtD
Vardenafil—Hypotension—Doxorubicin—muscle cancer	0.000801	0.00135	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—muscle cancer	0.000783	0.00132	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000781	0.00132	CcSEcCtD
Vardenafil—Insomnia—Doxorubicin—muscle cancer	0.000775	0.00131	CcSEcCtD
Vardenafil—Paraesthesia—Doxorubicin—muscle cancer	0.00077	0.0013	CcSEcCtD
Vardenafil—Dyspnoea—Doxorubicin—muscle cancer	0.000764	0.00129	CcSEcCtD
Vardenafil—Somnolence—Doxorubicin—muscle cancer	0.000762	0.00128	CcSEcCtD
Vardenafil—Dyspepsia—Doxorubicin—muscle cancer	0.000755	0.00127	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00074	0.00125	CcSEcCtD
Vardenafil—Pain—Doxorubicin—muscle cancer	0.000733	0.00123	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—muscle cancer	0.000729	0.00123	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—muscle cancer	0.00071	0.0012	CcSEcCtD
Vardenafil—Feeling abnormal—Doxorubicin—muscle cancer	0.000707	0.00119	CcSEcCtD
Vardenafil—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000701	0.00118	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—muscle cancer	0.000701	0.00118	CcSEcCtD
Vardenafil—Abdominal pain—Doxorubicin—muscle cancer	0.000678	0.00114	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—muscle cancer	0.000677	0.00114	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—muscle cancer	0.000655	0.0011	CcSEcCtD
Vardenafil—Hypersensitivity—Doxorubicin—muscle cancer	0.000632	0.00106	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—muscle cancer	0.00063	0.00106	CcSEcCtD
Vardenafil—Rash—Methotrexate—muscle cancer	0.000624	0.00105	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—muscle cancer	0.000624	0.00105	CcSEcCtD
Vardenafil—Headache—Methotrexate—muscle cancer	0.00062	0.00104	CcSEcCtD
Vardenafil—Asthenia—Doxorubicin—muscle cancer	0.000615	0.00104	CcSEcCtD
Vardenafil—Pruritus—Doxorubicin—muscle cancer	0.000607	0.00102	CcSEcCtD
Vardenafil—Nausea—Methotrexate—muscle cancer	0.000588	0.00099	CcSEcCtD
Vardenafil—Diarrhoea—Doxorubicin—muscle cancer	0.000587	0.000988	CcSEcCtD
Vardenafil—Dizziness—Doxorubicin—muscle cancer	0.000567	0.000955	CcSEcCtD
Vardenafil—Vomiting—Doxorubicin—muscle cancer	0.000545	0.000918	CcSEcCtD
Vardenafil—Rash—Doxorubicin—muscle cancer	0.000541	0.00091	CcSEcCtD
Vardenafil—Dermatitis—Doxorubicin—muscle cancer	0.00054	0.000909	CcSEcCtD
Vardenafil—Headache—Doxorubicin—muscle cancer	0.000537	0.000904	CcSEcCtD
Vardenafil—Nausea—Doxorubicin—muscle cancer	0.000509	0.000857	CcSEcCtD
